Finance

Lists
Why is 002900 down 3,21%?
Dive Deeper
002900:SHE
Harbin Medisan Pharmaceutical Co Ltd
11,16 CN¥
-3,21%
(-0,37) 1D
16 հոկ, 15:04:27 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002900...
Open
11,60 CN¥
High
12,30 CN¥
Low
11,03 CN¥
Mkt. cap
3,65 մլրդ
Avg. vol.
15,53 մլն
Volume
13,60 մլն
52-wk high
17,19 CN¥
52-wk low
8,93 CN¥
EPS
-0,92 CN¥
Shares outstanding
316,35 մլն
No. of employees
2 հզր
Open
11,60 CN¥
High
12,30 CN¥
Low
11,03 CN¥
Mkt. cap
3,65 մլրդ
Avg. vol.
15,53 մլն
Volume
13,60 մլն
52-wk high
17,19 CN¥
52-wk low
8,93 CN¥
EPS
-0,92 CN¥
Shares outstanding
316,35 մլն
No. of employees
2 հզր
News stories
From web sources and news partners
About Harbin Medisan Pharmaceutical Co Ltd
CEO-
Employees2,09 հզր
Founded21 հնս, 1996 թ.
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
167,53 մլն
208,77 մլն
228,84 մլն
199,96 մլն
Cost of goods sold
88,90 մլն
193,55 մլն
135,29 մլն
123,65 մլն
Cost of revenue
88,90 մլն
193,55 մլն
135,29 մլն
123,65 մլն
Research and development expenses
25,86 մլն
29,72 մլն
13,62 մլն
14,79 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
124,53 մլն
137,94 մլն
101,78 մլն
90,02 մլն
Operating expense
142,44 մլն
177,23 մլն
119,96 մլն
107,11 մլն
Total operating expenses
231,34 մլն
370,78 մլն
255,25 մլն
230,76 մլն
Operating income
-63,81 մլն
-162,01 մլն
-26,41 մլն
-30,80 մլն
Other non operating income
471,56 հզր
516,40 հզր
399,85 հզր
1,49 մլն
EBT including unusual items
-121,36 մլն
-127,18 մլն
-6,89 մլն
-42,24 մլն
EBT excluding unusual items
-63,30 մլն
-162,23 մլն
-24,15 մլն
-31,47 մլն
Income tax expense
-4,16 մլն
2,91 մլն
846,69 հզր
-4,65 մլն
Effective tax rate
3,43%
-2,29%
-12,29%
11,01%
Other operating expenses
-6,57 մլն
10,43 մլն
3,33 մլն
2,36 մլն
Net income
-116,45 մլն
-130,78 մլն
-7,06 մլն
-37,14 մլն
Net profit margin
-69,51%
-62,64%
-3,08%
-18,57%
Earnings per share
-
-
-
-
Interest and investment income
6,36 մլն
5,97 մլն
9,31 մլն
4,95 մլն
Interest expense
-5,98 մլն
-6,96 մլն
-7,44 մլն
-6,99 մլն
Net interest expenses
385,33 հզր
-990,84 հզր
1,86 մլն
-2,04 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-38,68 մլն
-128,83 մլն
6,77 մլն
3,78 մլն
Gain or loss from assets sale
-48,14 հզր
520,67 հզր
-
500,78 հզր
AI content may include mistakes. Learn more
Google Apps